Hikal Ltd
NSE:HIKAL

Watchlist Manager
Hikal Ltd Logo
Hikal Ltd
NSE:HIKAL
Watchlist
Price: 373.85 INR 2.06%
Market Cap: 46.1B INR
Have any thoughts about
Hikal Ltd?
Write Note

Hikal Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikal Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Hikal Ltd
NSE:HIKAL
Operating Expenses
-â‚ą8.2B
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Expenses
-â‚ą146.4B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Expenses
-â‚ą121.4B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Expenses
-â‚ą285.7B
CAGR 3-Years
-14%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Expenses
-â‚ą56.9B
CAGR 3-Years
-12%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Expenses
-â‚ą47.9B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hikal Ltd
Glance View

Market Cap
46.1B INR
Industry
Pharmaceuticals

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. The company is headquartered in Navi Mumbai, Maharashtra. The Company’s operating segments include the crop protection and pharmaceuticals space. The Crop protection produce and trades in pesticides and herbicides. Its facilities are in Taloja, Mahad (Maharashtra), and Panoli (Gujarat). The Pharmaceuticals space produce and trades in active pharmaceuticals ingredients. Its facilities are in Jigani (Bengaluru) and Panoli (Gujarat). The Company’s products and services include gabapentin, thiabendazole, and diuron contract development and custom manufacturing of intermediates, application programming interface (APIs), and artificial intelligence (AI’s). The company offers solutions to route scouting, process development, analytical method development, technology development, process engineering, scale-up support, and small-scale synthesis.

HIKAL Intrinsic Value
268.95 INR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Hikal Ltd's Operating Expenses?
Operating Expenses
-8.2B INR

Based on the financial report for Sep 30, 2024, Hikal Ltd's Operating Expenses amounts to -8.2B INR.

What is Hikal Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-9%

Over the last year, the Operating Expenses growth was -2%. The average annual Operating Expenses growth rates for Hikal Ltd have been -9% over the past three years , -9% over the past five years .

Back to Top